BCAN's Patient Handbook - Bladder Cancer Basics for the Newly Diagnosed



Donate Now to Support the Bladder Cancer Advocacy Network



Join The Online Bladder Cancer Support Community



The Bladder Cancer Advocacy Network (BCAN) is proud to announce that we have been designated a Marine Corps Marathon (MCM) Charity Partner! BCAN has been allocated 25 guaranteed entries for the 38th Annual Marine Corps Marathon to be held on October 27, 2013; an event that sold out in 2 hours and 41 minutes in 2012.
  • We are looking at building “Team BCAN” to not only run in the event and raise awareness for bladder cancer but to raise needed funds for fostering research and patient education. According to the Marine Corps Marathon, there is not a required qualifying time to participate in the event, but all runners should maintain at least a 14 minute mile pace. In order to become a member of “Team BCAN” and officially have a slot in this year’s race, you must be registered through BCAN.
  • No federal or Marine Corps endorsement is implied.
  • If you are interested in becoming a member of BCAN’s team or have any questions, please contact Larry Rzepka, BCAN’s Executive Director, at lrzepka@bcan.org.
  • ablerner.jpg
    Seth Lerner, M.D., FACS
    Professor of Urology
    Baylor College of Medicine

    Seth P. Lerner, M.D., is Professor of Urology and holds the Beth and Dave Swalm Chair in Urologic Oncology, in the Scott Department of Urology, Baylor College of Medicine. He earned his M.D. degree from Baylor College of Medicine and completed two years of General Surgery training at Virginia Mason Clinic in Seattle before returning to Baylor to complete his residency training in Urology. After a one-year AFUD/National Kidney Foundation fellowship and a one-year American Cancer Society fellowship in urologic oncology at the University of Southern California, he returned to Houston in 1992 to join the faculty of the Scott Department of Urology

    Scholar and teacher, author of more than 140 peer-reviewed articles, and co-editor of a widely used comprehensive Textbook of Bladder Cancer, Dr. Lerner is an active member of the prestigious American Association of Genitourinary surgeons and is listed routinely among “America’s Top Doctors” and “Best Doctors in America.” He is co-chair of the National Cancer Institute’s Bladder Cancer Task Force and bladder cancer disease working group for The Cancer Genome Atlas Project. He chairs the Local Bladder Committee of SWOG and serves on the Board of Directors for the Bladder Cancer Advocacy Network. He is active in international CME programs for the AUA, SUO, and ASCO and has served as Visiting Professor in places as varied as China, Australia, Germany, and Turkey. He directs the bladder cancer research program at Baylor and is founder of the Bladder Cancer Research Consortium.

    His research interests include use of selective estrogen receptor modulators for treatment of bladder cancer, gene therapy, targeted molecular therapeutics, and outcomes of radical cystectomy and pelvic lymphadenectomy. He currently serves as principle investigator for multiple clinical trials related to bladder cancer diagnosis and treatment.

    Click here for more information.